Gilead to launch generic versions of its hepatitis drugs
September 24, 2018 at 16:32 PM EDT
Gilead Sciences Inc said on Monday it plans to launch generic versions of its hepatitis C drugs in the United States, at a time when regulators are looking to lower healthcare costs.